These novel medications , Semaglutide , represent a significant advancement in managing metabolic dysfunction and possibly associated conditions . They are categorized as GLP-1 receptor agonists , meaning they to emulate the endogenous GLP-1 substance , boosting insulin release and suppressing hunger . While Tirzepatide every works somewhat simi… Read More